Boehringer and SBP Group Sign $7B Cancer Drug Deal
Ingelheim, Germany, and Hong Kong, China, November 4, 2026 Boehringer Ingelheim and Sino Biopharmaceutical Limited (SBP Group) have entered...
T-Cell Engagers
Advertisement
Henlius Partners With Amberstone on Next-Gen TCEs
Shanghai, China, September 24, 2026 Henlius has announced a strategic partnership with Amberstone Biosciences to discover and develop next-generation...
AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers
VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...
Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies
SAN DIEGO, Calif. and BOSTON, Mass., June 20, 2026 Voro Therapeutics and Alloy Therapeutics have announced a strategic research...
Jazz and AbCellera Partner on Next-Gen Cancer Antibodies
DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...
Advertisements
DISCO–Amgen License Deal Advances Surfaceome Cancer Therapies
COLOGNE, Germany – January 7, 2026 — DISCO Pharmaceuticals has entered into an exclusive global license agreement with Amgen...
Advertisement
